NASDAQ:RXST | Free Cash Flow | RxSight, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$10.89M$759,000.00-$11.65M
2025-12-31-$1.12M$1.14M-$2.25M
2025-03-31-$8.83M$575,000.00-$9.41M
2024-12-31-$4.26M$847,000.00-$5.11M
2024-03-31-$9.31M$1.97M-$11.28M
2023-12-31-$8.3M$1.59M-$9.89M
2023-03-31-$17.76M$747,000.00-$18.51M
2022-12-31-$13.85M$362,000.00-$14.22M
2022-03-31-$14.99M$370,000.00-$15.36M
2021-12-31-$8.72M$365,000.00-$9.09M
2021-03-31-$10.25M$498,000.00-$10.75M
2020-12-31-$8.23M$538,000.00-$8.77M-33.33%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$15.51M$3.83M-$19.34M
2024-12-31-$16.95M$5.44M-$22.39M
2023-12-31-$41.59M$4.81M-$46.41M
2022-12-31-$58.85M$2.39M-$61.24M
2021-12-31-$44.71M$1.94M-$46.65M
2020-12-31-$35.2M$2.54M-$37.74M-136.87%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.